Earlier this week UBS pharmaceutical analyst Roopesh Patel put out a big 2009 sector outlook research note claiming, "So far, the global economic slowdown has had no noticeable impact — a) U.S... Read More
Yesterday afternoon the "Journal of the American Medical Association" (JAMA) published a study showing that cheaper, generic heart drugs work just as well as more expensive, brand-name heart drugs... Read More
In a special edition 'Outrage of the Day,' Cramer has not one, but two gripes on his mind: one personal and one business, which is the one he decides to start with, since "we're not about making friends on this show, we're about making money."... Read More
When drug companies choose bullish, optimistic-sounding acronyms for clinical trials they should, perhaps, choose more wisely lest they backfire when the tests don't turn out like they hope they will... Read More